Clinical Trial Update: Dupilumab Compassionate Use Study

View source ↗

Summary

Dupilumab has received marketing approval for use in asthma, moving from a compassionate-use study to commercially available treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Sally E. Wenzel MD | Conditions: Asthma | Status: APPROVED_FOR_MARKETING